AstraZeneca wins patent infringement case over Farxiga generic

19-10-2021

Alex Baldwin

AstraZeneca wins patent infringement case over Farxiga generic

rarrarorro / Shutterstock.com

AstraZeneca has convinced a federal court to uphold challenged claims of a patent related to its diabetes drug Farxiga (dapagliflozin).


AstraZeneca, Farxiga, Zydus Pharmaceuticals, US District Court for the District of Delaware, Dapagliflozin, generics

LSIPR